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Abstract
Background. Overactive bladder (OaB) is a clinical entity with complex, still incompletely understood pathophys-
iology, involving central and peripheral autonomic nervous system (aNS) disturbances. 
Objectives. The aim of the study was to estimate aNS activity using spectral analysis of heart rate variability (HRV) 
in two experimental overactive bladder models: chemical, evoked by cyclophosphamide treatment (COaB), and 
obstructive, produced by proximal partial bladder outlet obstruction (OOaB).
Material and Methods. 10 COaB rats and 10 OOaB rats with appropriate control groups were studied (40 animals 
total were enrolled in the study). In all studied groups, resting HRV recordings were performed. Standard spectral 
HRV parameters were analysed. The bladder overactivity was confirmed by urodynamic recordings and histologi-
cal assessment. 
Results. In COaB, all non-normalized spectral HRV parameters were diminished, while OOaB rats were mostly 
characterized by pronounced Lf (Low frequency) and Hf (High frequency) decrease. Normalized (nLf and nHf) 
parameters achieved similar values in both COaB and OOaB comparing to appropriate controls. In the analysis of 
percentages of the individual components in the total HRV power, the OOaB group showed almost double VLf 
(Very Low frequency) percentage as compared to the control. OOaB rats also displayed the highest disproportion 
between VLf and both Hf and Lf percentages. Contrary to the OOaB, there were small differences in the percent-
age participation of the separate HRV components in COaB.
Conclusions. for both COaB and OOaB models, the authors demonstrated a decrease in the values of spec-
tral HRV parameters, which may reflect aNS disturbances. Moreover, in OOaB animals, apart from total HRV 
power reduction, exaggerated differences between VLf percentage and the remaining components were revealed. 
In authors’ opinion, their findings concerning VLf differences may reflect increased autonomic disturbances in 
the OOaB model (Adv Clin Exp Med 2013, 22, 3, 337–346).
Key words: overactive bladder, cyclophosphamide, bladder outlet obstruction, heart rate variability, autonomic 
nervous system.
Streszczenie 
Wprowadzenie. Zaburzenia patofizjologiczne leżące u podstaw rozwoju nadaktywności pęcherza moczowego są 
złożone i wciąż nie w pełni poznane. Patogeneza tej choroby jest związana między innymi z dysfunkcją autono-
micznej kontroli pęcherza.
Cel pracy. Oszacowanie aktywności autonomicznego układu nerwowego (aNS) za pomocą analizy widmowej 
(częstotliwościowej) zmienności rytmu serca (HRV) w dwóch doświadczalnych modelach pęcherza nadaktywnego 
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Overactive bladder (OaB) is a clinical entity 
with complex pathogenesis and symptomatology; 
its global prevalence approaches 11.8% (including 
10.8% of men and 12.8% of women). In general, 
OaB affects all ages, but its occurrence increases 
with aging and is more common in women than 
in men [1].
OaB was defined in 2002 by the International 
Continence Society (ICS) as urinary urgency with 
or without urge incontinence, usually associated 
with frequency and nocturia, in the absence of 
proven bladder disorders [2]. However, the OaB 
description, including the diagnostic and thera-
peutic guidelines, has been evolving. The current 
OaB definition, revised in 2006, constitutes ur-
gency with or without urgency incontinence (UI), 
usually with increased daytime frequency and 
nocturia. “Urgency” is defined as “the complaint 
of a sudden compelling desire to pass urine, which 
is difficult to defer” [3, 4]. Thus, “urgency urinary 
incontinence” is “the complaint of involuntary 
leakage accompanied by or immediately preceded 
by urgency”; “increased daytime frequency” is “the 
complaint by the patient [...] that he/she voids too 
often by day”, while “nocturia” is defined as “the 
complaint that the individual has to wake at night 
one or more times to void” [3, 4].
The mechanisms that underlie OaB are com-
plex and still incompletely understood. generally, 
the urinary bladder plays a role in urine storage 
and voiding. Its functioning is regulated by the 
peripheral and central nervous systems. The blad-
der is innervated with both the sympathetic nerves 
(originating from the intermediolateral nuclei in 
the thoracolumbar region (Th10-L2) of the spinal 
cord) and the parasympathetic ones (arising from 
the sacral S2-S4 spinal parasympathetic nucleus). 
Detrusor contractions, which are responsible for 
bladder emptying, are initiated via acetylcholine 
(ach) release and muscarinic receptors activation. 
Two main periods in bladder functioning may be 
distinguished: storage and emptying (voiding). 
Physiologically, during the storage phase, no spinal 
parasympathetic activity or bladder contractions 
occur, while an increased sympathetic discharge 
contributes to bladder relaxation with urethral 
smooth muscle and urethral and pelvic floor striat-
ed muscles keeping the outflow closed. In contrast, 
during voiding, the decreased sympathetic activity 
contributes to bladder outflow opening, which in 
connection with increased parasympathetic input, 
lead to bladder contractions and emptying. Hence, 
normal bladder function is dependent on the in-
tricate interplay of neurogenic and myogenic cells; 
disruption of any of these may lead to urinary dys-
function [5, 6]. 
Two main theories, neurogenic and myogenic, 
have been proposed to address the pathophysi-
ological processes. The first focuses on the cen-
tral and peripheral autonomic nervous systems 
(aNS) disturbances affecting bladder contractility 
and functioning. The main neurogenic theory de-
scribes the pathophysiological problem of OaB in 
connection with the damage of descending inhibi-
tory pathways arising from higher brain centers, 
while according to the peripheral neural theory, 
OaB development results from an increased sen-
sitization of bladder afferent terminals. Regardless 
of the central or peripheral reason, generalized, 
nerve-mediated excitation of the detrusor muscle 
(OaB): chemicznego (COaB), wywołanego przez podawanie cyklofosfamidu oraz obstrukcyjnego (OOaB), zwią-
zanego z częściową, podpęcherzową blokadą odpływu moczu. 
Materiał i metody. Badania przeprowadzono na grupie 40 szczurów, podzielonych na dwie grupy z danym mode-
lem OaB (COaB, OOaB) oraz dwie odpowiednie im grupy kontrolne (liczebność każdej z grup n = 10). W każdej 
z badanych grup przeprowadzono spoczynkowe zapisy zmienności rytmu serca, oceniając standardowe parametry 
widmowe. Nadaktywność pęcherza była potwierdzana badaniami urodynamicznymi oraz morfologiczną i histolo-
giczną oceną tkanek pęcherza. 
Wyniki. W grupie COaB wartości wszystkich nieznormalizowanych parametrów analizy spektralnej były zmniej-
szone, podczas gdy w grupie OOaB zaznaczył się głownie spadek składowej niskiej (Lf) i wysokiej i (Hf) często-
tliwości. Znormalizowane parametry (nLf i nHf) osiągały podobne wartości w obydwu grupach z OaB i odpo-
wiadającym im grupach kontrolnych. Oceniając procentowy udział poszczególnych składowych w mocy całkowitej 
widma HRV, w grupie OOaB uwidoczniono niemal dwukrotnie większy odsetek składowej bardzo niskiej czę-
stotliwości (VLf) w porównaniu z odpowiednią grupą kontrolną. Ponadto grupę OOaB cechowała największa 
dysproporcja między odsetkową wartością VLf i pozostałymi składowymi widma (Lf i Hf). Przeciwnie, w grupie 
COaB, różnice między procentowym rozkładem składowych widma HRV nie były aż tak zaznaczone, w porówna-
niu do odpowiedniej grupy kontrolnej. 
Wnioski. Zarówno w grupie COaB, jak i OOaB wykazano zmniejszenie wartości parametrów analizy widmowej 
HRV, co sugeruje zaburzenia autonomicznego układu nerwowego. Ponadto grupę OOaB cechowała zaznaczona 
dysproporcja w procentowym rozkładzie VLf i pozostałych składowych widma. Wyniki te mogą wskazywać na 
bardziej nasilone zaburzenia autonomicznego układu nerwowego w tym modelu OaB model (Adv Clin Exp Med 
2013, 22, 3, 337–346).
Słowa kluczowe: pęcherz nadaktywny, cyklofosfamid, częściowa blokada podpęcherzowa, zmienność rytmu serca 
(HRV), autonomiczny układ nerwowy.
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takes place. The myogenic theory suggests that 
bladder over-reactivity may be associated with re-
modeling of the bladder wall and abnormal elec-
trical excitation of cells resulting from excitatory 
stimulus spreading across a large number of cou-
pled smooth muscle cells [5, 7]. The detailed de-
scription of both the anatomical and physiological 
aspects fundamental to the neural and myogenic 
theories of OaB development goes beyond the 
constraints of the present work. Basic OaB patho-
physiology concepts with current management 
and future OaB pharmacotherapy perspectives 
were discussed in the authors’ reviews published 
in the last year [8, 9].
In view of the neurogenic OaB pathophysi-
ological theory, it is necessary to assess the auto-
nomic nervous system. In humans, the “ewing car-
diovascular tests battery” and catecholamine level 
measurements evaluate aNS activity [10]. How-
ever, according to current guidelines, the heart 
rate variability (HRV) study is regarded to be the 
best non-invasive method of aNS indirect assess-
ment for both experimental and clinical purposes. 
Heart rate variability phenomenon is the tempo-
rary variation of normal to normal beat intervals, 
observed in an eCg recording of the subject with 
dominant sinus rhythm, that is influenced by car-
diac autonomic innervation [11, 12]. Two main 
types of HRV analysis may be distinguished: time 
domain analysis, based on mNN [ms] (main pa-
rameter) as well as other statistical derivatives, and 
frequency (spectral) analysis, that is based on the 
HRV power spectrum and its components (TP 
– Total Power, VLf – Very Low frequency, Lf 
– Low frequency – and Hf – High frequency) as-
sessment. generally, the total HRV power (TP) re-
flects global autonomic tension, Lf – sympathetic/
parasympathetic tone, nLf (normalized Low fre-
quency) – pure sympathetic or Hf, nHf (normal-
ized High frequency) – pure parasympathetic 
activity. There is no unanimous agreement con-
cerning VLf; however, this component is believed 
to mirror both the various short-term physiologi-
cal regulations as well as autonomic inflammatory 
influences [11–13].
Thus, one may ask what kind of autonomic 
dysfunctions are present in the two entities – hem-
orrhagic cystitis (during cyclophosphamide treat-
ment) and bladder outlet obstruction, both mani-
fested by OaB symptoms, but resulting from other 
pathogenic mechanisms.
The aim of this study was an autonomic activ-
ity assessment using HRV spectral analysis estima-
tion in the two animal models of overactive blad-
der (OaB) – evoked by cyclophosphamide (CYP) 
administration (chronic chemical OaB; COaB 
– Chronic Overactive Bladder) and by partial ure-
thral obstruction (bladder outlet obstruction – ob-




The study was conducted after obtaining the 
first Local ethic Committee in Cracow agreement 
(decision No 126/2010).
Animals and Studied Groups
The authors used rats from the Pharmacy 
Department animal house. firstly, after arrival 
at the Pathophysiology Department, the animals 
were kept in groups of five per cage for one week 
to assure them the acclimatization period to new 
laboratory conditions. In general, the animals 
were housed with the retaining of 12–12 hours 
day-night cycle, room temperature, standard food 
(Labofeed, Kcynia) and ad libitum water.
after the acclimatization period, the animals 
were randomized into studied groups. The authors 
carried out their experimental research in two es-
sential groups: with COaB and OOaB models, 
with two suitable control populations. Therefore, 
four groups were studied: COaB (mean body 
weight 289.3±42.0 g), control group (1) (mean 
body weight 273.3±36.0 g), OOaB (mean body 
weight 243.3±13.5 g) and control group (2) (mean 
body weight 236.3±6.3 g). each group consisted of 
ten 10-week-old female Wistar rats; thus the ex-
periment employed 40 animals.
COAB Model
Cyclophosphamide (CYP) – an oxazaphospho-
rine chemotherapeutic agent, was administrated 
intraperitoneally (i.p.) to evoke a model of hem-
orrhagic cystitis (HC) with bladder overactivity. 
In general, taking into consideration CYP dose 
and route of administration, there is a possibility 
to induce the so-called “acute overactive bladder” 
(aOaB) model, or a chronic case (COaB) [14, 15]. 
The authors conducted their study on the COaB 
model caused by cyclophosphamide (Sigma-al-
drich; 75 mg/kg body weight), administered i.p. 
four times every third day during one week (the 
1st, 3rd, 5th and 7th day). This resulted in a chron-
ic chemical bladder inflammation [14, 15]. Two 
animals did not survive CYP therapy, thus, in the 
end, the authors studied 8 COaB rats. The pro-
gressive haematuria in all remaining COaB sub-
jects after the last CYP dose was revealed, which 
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was also the next evidence for bladder inflamma-
tory change intensification. On the 8th day, after 
HRV recording registration, the animals were eu-
thanized using a pentobarbital (Morbital, Biowet, 
Puławy) overdose (100 mg/kg body weight).
Control Group (1)
The studied animals received saline i.p. in-
jection four times (similarly to COaB) in similar 
amounts as those ones administrated in the COaB 
rats. HRV recordings were also performed on the 
8th day of the experiment.
OOAB Model
The animals enrolled into the OOaB group 
underwent surgery to evoke partial bladder out-
let obstruction associated with secondary bladder 
overactivity. The experimental method used to 
produce bladder outlet obstruction was described 
previously by several investigators [16, 17]. Brief-
ly, rats were anesthetized i.p. with pentobarbital 
(brand name: Morbital, Biowet, Puławy; 35 mg/
kg body weight). In the surgical procedure, the 
authors exposed the bladder and proximal ure-
thra through an abdominal midline incision and 
placed a 1 mm diameter stainless steel rod to the 
proximal urethra to tie a 4/0 silk ligature around 
the inserted rod. after experimental urethral nar-
rowing, the catheter was removed, leaving the ure-
thra partially occluded. The abdominal wall was 
sutured and the animals were allowed to recover. 
During the first three days of the recovery period, 
two antibiotics (neomycin – Neomycin spray, oxy-
tetracycline – Oxycort spray) were administrated 
to the surgery wound to prevent inflammatory 
complications. at 2 weeks after surgery, HRV re-
cordings were collected.
Control Group (2)
10 rats underwent sham surgery in which the 
authors also exposed the bladder and catheterized 
the proximal urethra but without its ligation. The 
post-surgery protocol was similar to the OOaB an-
imals. Consistently, HRV studies were performed 
2 weeks after the sham procedure, similarly to the 
OOaB animals.
HRV Studies
20 minute eCg recordings were performed 
in resting conditions under urethane anesthe-
sia (1200 mg/kg body weight; Sigma-aldrich) in 
the studied animals. Urethane was chosen based 
on literature reports suggesting its proportional 
(up to the applied dose) influence on both sym-
pathetic and parasympathetic tonic activity, and 
a relatively small impact on cardiac reflexes [18, 
19]. after extrasinusal extopics elimination, the 
remaining sinus eCg signal was subjected to 
HRV analysis to obtain standard spectral (VLf, 
Lf, Hf and TP – all expressed in [ms*ms] and 
normalized nLf and nHf, calculated in normal-
ized units [n.u.]) parameters. The authors set 
the range for the respective spectral components 
at: 0.18<VLf<0.28<Lf<0.78<Hf<3; and admit-
ted commonly accepted interpretation criteria, as 
mentioned in the introduction. The initial results 
were calculated as values ± SD.
Bladder Overactivity 
Verification
In the last step, after HRV registration, 45 min-
ute urodynamic recordings were conducted to con-
firm bladder overactivity in all the studied groups.
The authors also performed the urodynamic 
recordings using urethane because this anesthetic 
agent is regarded to have a relatively small potential 
for impairing urinary bladder motility, as mentioned 
previously [18, 19]. In the still anaesthetized rat, the 
abdomen was opened and the bladder was exposed 
using similar surgery as that applied in the OOaB 
and control (2) groups. a urodynamic polyethylene 
catheter (external diameter 0.97 mm/internal diam-
eter 0.58 mm, BaLT Poland), was inserted into the 
bladder dome through a small incision and fixed in 
place with 4-0 silk ligature. The catheter was con-
nected to a pressure transducer that is a part of the 
analysis hardware (Power Lab; Chart 5 Pro v.5.4.2, 
aD Instruments). after bladder catheterization and 
system calibration, a 15 minute stabilization period 
was allowed. following the initial procedures, the 
baseline recordings were registered during con-
tinuous saline infusion at a rate of 0.046 ml/min 
for 30 minutes (using an injection pump Unipan 
340a). During the urodynamic studies, as well as 
the HRV ones, the studied animals were put under 
a heating lamp to avoid a body temperature fall 
through the uncovered abdominal layers that could 
negatively influence bladder activity and autonomic 
tension. Based on the obtained urodynamic record-
ings, the authors calculated standard urodynamic 
parameters (peak number – PN, peak number per 
minute – PNM, intercontraction interval – ICI [s] 
and micturition voiding pressure – MVP [cm H2O]) 
to ascertain bladder contractility. 
The examples of registered urodynamic fig-
ures, obtained in both control groups 1 and 2 
(fig. 1), as well as in the COaB (fig. 2) and OOaB 
(fig. 3) animals are given below.
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The authors checked that both the COaB and 
BOO (Bladder Outlet Obstruction) animals dis-
played urodynamic OaB findings by performing 
a visual urodynamic records inspection as well as 
calculating the values of urodynamic parameters. 
In the case of these groups, the authors observed 
increased global bladder contractility (manifested 
in PN together with PNM increase and ICI and 
MVP decrease, as compared to the control).
The control rats (sham-operated or treated) 
displayed normal bladder contractility without 
urodynamic features of its overactivity. The au-
thors have concluded that this finding may also 
be regarded as further indirect evidence of bladder 
disturbances recorded in BOO animals.
Statistical Analysis
The authors performed a statistical estimation 
of the obtained results in paired studied groups 
(COaB vs. control 1 and OOaB vs. control 2), af-
ter expressing them in the natural logarithmic val-
ues, using a parametric fischer-Snedecor test with 
α = 0.05. The necessity of the HRV spectral param-
eter values’ expression in the form of their natural 
logarithms was the consequence of the lack of their 
normal distribution. The authors verified the null 
(H0) hypothesis of equality of analyzed parameter 
variations in the two studied populations versus the 
alternative H1 hypothesis of their inequality (thus, 
their statistically significant differences).
Urinary Bladder Assessment
The bladders were collected in both COaB 
and OOaB rats, as well as in the controls, after 
urodynamic recordings and pentobarbital over-
dose (100 mg/kg body weight). In the OOaB sub-
jects, before bladder excision, the authors careful-
ly removed the urethral ligature. In both studied 
Fig. 1. an example of the uro-
dynamic recordings obtained in 
control rats
Ryc. 1. fragment zapisu uro-
dynamicznego rejestrowanego 
w grupie kontrolnej
Fig. 2. an example of the uro-
dynamic recordings obtained in 
COaB rats
Ryc. 2. fragment zapisu uro-
dynamicznego rejestrowanego 
w grupie COaB
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groups, the authors revealed gross inflammatory 
changes (the bladders were swollen, red, and in 
most cases covered by abundant serosal petechial 
suffusions). In a microscopic bladder assessment, 
leukocyte infiltration was demonstrated in both 
OOaB and COaB groups, however, the observed 
histological inflammatory lesions were more pro-
nounced in rats with HC development due to CYP 
treatment. The control rats displayed no morpho-
logical or histological bladder abnormalities.
Results
The statistical estimation of spectral HRV pa-
rameters (expressed as ln values) showed inter-
group differences (control 1 vs. COaB and con-
trol 2 vs. OOaB) referring to all non-normalized 
spectral parameters.
With regards to COaB and control 1 group, it 
should be noted that all non-normalized spectral 
HRV parameters were lower in COaB rats and the 
differences were statistically significant. In OOaB, 
a pronounced decrease in Lf and Hf values was re-
vealed when compared to control 2 group, whereas 
VLf reached almost the same value in both analyzed 
populations. OOaB rats were also characterized by 
a low TP value. Contrariwise to the results described 
above, the normalized (nLf and nHf) spectral pa-
rameters achieved in all studied groups (COaB and 
OOaB) were similar as compared to the suitable 
controls and did not possess statistical significance.
The results referenced above are given in Ta-
ble 1.
Moreover, intergroup differences (control 1, 
COaB, control 2, OOaB) of the non-normalized 
HRV parameters (VLf, Lf, Hf) were also calcu-
lated as an expression of their percentage partici-
pation related to the total power in each group. 
When compared in the appropriate pairs (COaB 
vs. control 1 and OOaB vs. control 2), more pro-
Fig. 3. an example of the uro-
dynamic recordings obtained in 
OOaB rats
Ryc. 3. fragment zapisu urodyna-
micznego rejestrowanego w gru-
pie OOaB
Table 1. HRV frequency (spectral) domain analysis parameters













COaB control (1) OOaB control (2)
ln TP 0.24 ± 1.10 1.65 ± 1.09 p = 0.002 2.06 ± 1.77 3.46 ± 0.59 p = 0.027
ln VLf 0.03 ± 1.19 1.44 ± 1.22 p = 0.003 1.89 ± 1.84  2.56 ± 1.16 p = 0.208
ln Lf –3.24 ± 1.25 –1.57 ± 1.17 p = 0.001 –1.11 ± 2.00 1.60 ± 0.47 p = 0.002
ln Hf –2.02 ± 1.21 –0.77 ± 0.82 p = 0.002 –0.88 ± 1.80 2.18 ± 0.86 p = 0.001
Lf/Hf 0.51 ± 0.55 0.67 ± 0.64 p = 0.255 1.06 ± 0.75 0.70 ± 0.63 p = 0.183
nLf [n.u.] 27.54 ± 19.61 33.76 ± 19.50 p = 0.216 45.2 ± 19.67 36.61 ± 16.04 p = 0.199
nHf [n.u.] 72.46 ± 19.62 66.25 ± 19.50 p = 0.216 54.8 ± 16.72 63.39 ± 16.04 p = 0.198
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nounced differences were revealed for the animals 
from OOaB/control 2 than from COaB/control 
1. The OOaB group showed almost double the 
VLf percentage compared to control 2, while Lf% 
was almost three times, and Hf% – almost four 
times lower. OOaB rats also displayed the highest 
disproportion between VLf and Hf percentages 
among all the analyzed groups. Contrary to the 
OOaB and control 2 rats, the differences in per-
centage participation of the separate HRV com-
ponents in COaB and control 1 group were very 
small. In these populations, similar values of HRV 
power spectrum percentage distribution were ob-
served. The results described above are presented 
in figures 4 and 5 below.
Discussion
The main conclusion of this study was the 
demonstration of autonomic abnormalities in 
both the CYP-induced hemorrhagic cystitis 
(COaB) and bladder outlet obstruction (OOaB). 
Both COaB and OOaB groups were character-
ized by diminished global aNS tension and lower 
values of the non-normalized HRV components. 
These differences were especially pronounced for 
Lf and Hf. However, in both groups, normalized 
Lf and Hf comparing to appropriate controls did 
not differ significantly. Thus, the VLf differences 
seem to possess a particular significance. The VLf 
relations to the remaining HRV components were 
more visible in the intergroup comparison when 
the percentages of individual HRV components 
in each group were calculated (figures 1 and 2). 
In OOaB/control 2 groups, the disproportion be-
tween %VLf/%Lf/%Hf was clearly emphasized, 
while in COaB/control 1 they were not so dis-
tinct.
The TP and all non-normalized HRV param-
eters decrease in both OaB rats may be a conse-
quence of autonomic damage caused by either 
chemical or mechanical chronic stimuli. accord-
ing to the HRV components interpretation, it 
seems that autonomic disturbances observed in 
both COaB and OOaB rats affect both the sym-
pathetic and parasympathetic branch. a common 
agreement exists that efferent vagal activity is 
a major contributor of the Hf component. Many 
experimental and clinical studies of autonomic 
maneuvers, such as electrical vagal stimulation, 











































Fig. 4. Percentage participation in total power 
of particular spectral components in control and 
COaB rats
Ryc. 4. Udział procentowy poszczególnych 
składowych widma w grupie kontrolnej i COaB
Fig. 5. Percentage participation in total power 
of particular spectral components in control and 
OOaB rats
Ryc. 6. Udział procentowy poszczególnych 
składowych widma w grupie kontrolnej i OOaB
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carinic receptor blockage/excitation have pro-
duced pronounced changes in Hf tension. The 
interpretation of the origin of the Lf component 
is more controversial and ambiguous. Lf is con-
sidered to be either a marker of pure sympathetic 
modulation (especially when expressed in normal-
ized units – nLf increase is observed during tilt or 
mental or physical stress which activates the sym-
pathetic branch) or a parameter reflecting both 
the sympathetic and parasympathetic influences. 
Moreover, during sympathetic overexcitation, Lf 
power was even found to be diminished, reflecting 
the decreased responsiveness of the sinus node to 
the neural inputs [11, 20].
a reduction in HRV has mostly been observed 
in cardiac diseases. Patients with myocardial in-
farction, following cardiac transplantation or suf-
fering from chronic heart failure, are character-
ized by decreased heart rate variability. Similarly, 
patients with diabetes also present reduced HRV 
and this finding is regarded to be a marker for the 
development of autonomic neuropathy [11, 20].
In the urology field, studies focused on aNS 
assessment and HRV are rare. In a Choi et al. 
study [21], lower spectral parameters in female 
patients with idiopathic OaB were found, thus 
suggesting impaired autonomic functioning in this 
population. In one of the latest published works, Ben-
Dror et al. [22] also demonstrated a reduced sympa-
thetic tone (reflected in lower Lf values) during blad-
der filling in women with idiopathic OaB. Moreover, 
they revealed that in women with OaB, sympathetic 
activity decreased before maximal bladder capacity 
was reached. Because continual increase in sympa-
thetic activity during bladder filling is necessary to 
enable the bladder to expand without detrusor con-
tractions, the observed sympathetic dysfunction may 
result in sensation of urgency [22].
In another study, Juszczak et al. [23], using 
autonomic ewing’s battery tests, revealed rest-
ing sympathetic overstimulation in benign pros-
tatic hyperplasia (BPH) patients with concurrent 
bladder overactivity symptoms. Moreover, di-
minished suspected parasympathetic response to 
vagal stimulation during deep breathing tests was 
demonstrated. Taking into consideration the re-
sults obtained, they concluded that these patients 
developed mixed autonomic disturbances [23]. 
Other investigators confirmed autonomic neurop-
athy in BPH patients. Both Mc Vary et al. [24] and 
Meigs et al. [25] found that patients with BPH are 
more likely to have sympathetic overactivation. 
They also revealed an indisputable dependence 
between BPH development and sympathetic over-
activity. Thus, according to these authors, aNS 
disturbances may have a causal meaning in BPH 
development and progression.
It is difficult to uncritically and simultane-
ously compare results obtained from clinical and 
experimental results. There are essential meth-
odology differences (e.g. Ben-Dror [22] – HRV 
estimating throughout monitored bladder filling; 
the present experiment – HRV assessment inde-
pendently on bladder phase) and also the impor-
tant limitations of animal modeling. first of all, 
OaB is a symptom-based condition in which the 
conscious perception of urgency is central to the 
diagnosis. There is no way of knowing certainly 
whether an animal is experiencing urgency, even 
if pseudo-affective changes in behavior may sug-
gest it. Moreover, none of the animal models can 
reproduce all the facets of human conditions. 
Thus, it must be emphasized that an OaB animal 
model is a tool rather than a replica and is usually 
only relevant to the complex human condition with 
regards to resolving a particular experimental hy-
pothesis. However, it is widely accepted that studies 
using muscle strips or animal OaB models provide 
a crucial link to the clinical context, enabling both 
a more detailed pathophysiological description and 
discovering more effective treatment [26].
Most animal models used to study OaB are 
induced models, meaning that a relevant patho-
physiological challenge is experimentally applied 
to a healthy animal. One of the peripheral models, 
chronic chemical hemorrhagic cystitis (HC), re-
sults from direct damage to the bladder evoked by 
chronic or single cyclophosphamide (CYP) admin-
istration. This model, first proposed by Cox [27], 
reflects bladder damage with its overactivity in 
the course of oxazaphosphorine therapy and is 
frequently used, often with minor modifications, 
by numerous researchers in the OaB field. The 
other OaB experimental model, reflecting bladder 
outlet obstruction (BOO), produces storage symp-
toms that often persist even after the obstruction is 
surgically corrected. Disturbances similar to those 
observed in human BOO are relatively straightfor-
ward to reproduce in experimental conditions by 
ligating the urethra to produce partial obstruction. 
This experimental approach also reflects urethral 
obstruction due to benign prostatic hyperplasia 
(BPH) in men, often associated with OaB symp-
toms [26, 28]. Thus, much of the current knowl-
edge from this field has come from experimental 
studies and not only from clinical ones.
However, despite the restrictions mentioned 
above, the authors again revealed the decrease in 
the main HRV spectral parameters in both OaB 
features – chemically and mechanically induced. 
However, in COaB, the global aNS activity de-
crease was accompanied by maintaining the mu-
tual proportion between HRV individual com-
ponents as compared to the appropriate control 
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group (fig. 1). Contrary to this, in the OOaB 
animals, apart from total power reduction, there 
were differences between VLf percentage and the 
remaining components with regards to VLf in-
crease in total aNS activity. Hence, in the authors’ 
opinion, the VLf apparent, relative increase in 
OOaB may constitute the key element, depending 
on the causative character (mechanical or chemi-
cal) of the OaB etiological agent. However, it is 
not possible to interchangeably elucidate whether 
augmented sympathetic or parasympathetic ten-
sion contributes to the revealed VLf changes, be-
cause the mechanisms responsible for VLf devel-
opment in the HRV spectrum remain unknown 
and require further clarifying.
as was already mentioned in the introduc-
tion, VLf is regarded as reflecting neuroendocrine 
rhythms, thermoregulatory actions, renin-angio-
tensin system activity, and hemodynamic feed-
back delays. Regardless of the only partly defined 
VLf origin mechanisms, there is great interest in 
this component with regards to humans. The slow 
rhythms reflected in the HRV spectrum in very 
low – VLf and even ultra-low frequencies – ULf 
ranges are said to be predictors of severe cardiac 
disorders, including cardiac death [11]. Thus, de-
spite the fact that an unambiguous VLf meaning is 
still not clearly determined, most HRV guidelines 
consider this spectral component as a determinant 
of sympathetic tension. In this view, the authors’ 
findings regarding VLf in the OOaB group may 
be due to sympathetic overactivity associated with 
simultaneous parasympathetic withdrawal. On the 
other hand, there are also premises to regard VLf 
as the reflection of parasympathetic excitation. 
according to Taylor et al. [29], VLf mainly results 
from the parasympathetic outflow, not the sympa-
thetic. These authors demonstrated that atropine 
administration led to almost complete VLf power 
abolishment and other spectral components powers 
reduction, suggesting that the VLf band is driven 
by parasympathetic tension. Silva Soares et al. [30] 
revealed in their study that stimulation with pyr-
idostigmine (a reversible cholinesterase inhibitor) 
produced a strong increase in VLf [30]. Therefore, 
contrary to the clinical observations in cardiology 
suggesting a strong link between VLf power and 
sympathetic-mediated severe cardiac disturbances, it 
seems that VLf oscillations may also derive from the 
parasympathetic mechanisms. Taking into account 
such a point of the view, the authors’ VLf findings 
may also reflect parasympathetic predominance, 
contributing to the exaggerated but ineffective blad-
der motor activity in bladder outlet obstruction and 
resulting in overactive bladder symptoms. Chemical 
bladder damage caused by CYP and its metabolites 
could be reflected to a larger degree in the range be-
yond very low frequency.
The authors revealed autonomic nervous sys-
tem disturbances in both CYP-induced hemor-
rhagic cystitis (COaB) and bladder outlet obstruc-
tion (OOaB). 
Both COaB and OOaB groups were char-
acterized by diminished global aNS tension and 
lower values of Lf and Hf values. However, in 
both groups, normalized Lf and Hf did not dif-
fer significantly when compared to appropriate 
control subjects. VLf percentage, calculated as an 
expression of its participation related to the appro-
priate total power was the highest in OOaB. Con-
trary to these findings, COaB rats displayed very 
small differences in percentage participation of the 
separate HRV components. Thus, the VLf differ-
ences seem to possess a particular significance in 
OaB associated with bladder outlet obstruction. 
The authors realize that the conclusion on 
the differential role of VLf in OaB may be pre-
mature and too far-reaching. However, in their 
opinion, this finding seems to be very interesting 
and worth detailed exploration, being a promis-
ing research direction for further theoretical and 
clinical studies.
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